Tumor Necrosis Factor: What Is in a Name?
Tumor Necrosis Factor was one of the first cytokines described in the literature as a soluble mediator of cytotoxicity to tumors. Over the years, more extensive research that tried to employ Tumor Necrosis Factor in cancer treatments showed nevertheless that it mainly functioned as a proinflammatory...
Main Authors: | Xinming Wang, Chunlan Yang, Heinrich Körner, Chaoliang Ge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/21/5270 |
Similar Items
-
Editorial: Reviews and advances in inflammatory diseases and the tumor necrosis factor
by: Cristian R. Smulski
Published: (2024-04-01) -
Entamoeba histolytica – tumor necrosis factor: a fatal attraction
by: Serge Ankri
Published: (2015-07-01) -
Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
by: Hideki Kitaura, et al.
Published: (2022-01-01) -
Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma
by: Kondkar AA, et al.
Published: (2018-01-01) -
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
by: Lienggonegoro LA, et al.
Published: (2023-09-01)